Medical Devices Research Reports Medical Cyclotrons Market | Page 3
Medical Cyclotron Market - Regional Insights
On the basis of Geography, medical cyclotron market is segmented into North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is projected
to hold a dominant position in the medical cyclotron market. The U.S. also has one of the
highest prevalence of the cancer in the world which would indirectly create greater need
for PET scan and eventually medical cyclotron. According to a report by American Cancer
Society, in 2018, cancer is the second leading cause of death after cardio vascular
disease. Furthermore, the report projected around 1.7 million new cases of cancer and
around half million deaths due to the disease. Such high prevalence of cancer increases
the demand for PET scans, which in turn is expected to propel the market growth. For
instance, according to Centre for Disease Control statistics 2017, around 2 million PET
scans are conducted in the U.S, annually. High prevalence of non-communicable
diseases in emerging economies in Asia Pacific is expected to increase healthcare
spending in the region and increasing utilization and development in nuclear medicine
and its adaptation. For instance, International Atomic Energy Association (IAEA), in 2017
collaborated with European Association of Nuclear Medicine (EANM) to facilitate nuclear
medicine professionals with training courses, educational materials and quality
infrastructure for nuclear medicine and hybrid imaging.
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/ongoing-insight/medical-cyclotrons-market-
2039
Medical Cyclotron Market - Competitive Landscape
Key players operating in the medical cyclotron market include, IBA, Advanced Cyclotron
Systems, Inc., GE Healthcare, Siemens Healthineers USA, Inc., Sumitomo Heavy
Industries, Ltd., and Best Cyclotron Solutions Inc. Key players are focused on launching
advanced and reliable medical cyclotron products to expand their market share. For
instance, in 2016, IBA launched –Cyclone KIUBE—at the 2016 Society of Nuclear
Medicine and Molecular Imaging (SNMMI) annual meeting in San Diego, California, U.S.
It is an 18 MeV fixed energy cyclotron with compact design and is cost-effective as it
provides production of almost all possible radioisotopes used currently in PET scan
diagnostic.